Influenza Vaccine Effectiveness and Uptake in Children at Risk of Severe Disease
Authors:
- Christopher C BlythCBChristopher C Blyth
- Peter JacobyPJPeter Jacoby
- Paul V EfflerPEPaul V Effler
- Heath KellyHKHeath Kelly
- David W SmithDSDavid W Smith
- Meredith L BorlandMBMeredith L Borland
- Gabriela A WillisGWGabriela A Willis
- Avram LevyALAvram Levy
- Anthony D KeilAKAnthony D Keil
- Peter C RichmondPRPeter C Richmond
- WAIVE Study TeamWTWAIVE Study Team
- 1 March 2016
- journal article
- review article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 35 (3) , 309-315
Abstract
Data demonstrating the effectiveness of inactivated trivalent influenza vaccine (TIV) for children at increased risk of severe disease are limited. Our objective was to determine the effectiveness of TIV in children with risk factors for severe disease and to compare vaccine uptake, parental attitudes and prescriber recommendations in children with and without risk factors for severe disease. Children aged 6-59 months presenting for emergency care (2008 to 2014) with an influenza-like illness were eligible. Influenza polymerase chain reaction/culture was performed on nasopharyngeal samples. Vaccination status was confirmed via the national register and/or vaccine providers. The test-negative design was used to estimate vaccine effectiveness (VE). Risk factors, parental attitudes and prescriber recommendations were assessed by parental questionnaire. Two thousand seven hundred twenty-three children were recruited. Risk factors for severe disease included comorbid medical conditions (11.6%), preterm birth (13.0%) and indigeneity (5.0%). Influenza was identified in 546 (20.1%) participants. Overall VE (2008 and 2010 to 2014) was 70.0% (95% confidence interval: 47.7 to 82.9); VE for children with medical comorbidities, children born preterm and children <2 years were 82.5% (14.6 to 96.4), 79.2% (10.9 to 95.1) and 84.7% (49.6 to 95.3), respectively. After adverse events in 2010, the number of children fully vaccinated with TIV declined significantly. This included children with and without risk factors for severe disease. Attitudes were similar in parents of children with and without risk factors for severe disease. VE for TIV in young children with and without risk factors for severe disease was ≥70%. Despite this, participation in the preschool influenza vaccination program remains low with parents and prescribers unconvinced of the benefits and safety of TIV.Keywords
This publication has 24 references indexed in Scilit:
- Identification of children at risk of influenza-related complications in primary and ambulatory care: a systematic review and meta-analysisThe Lancet Respiratory Medicine, 2015
- The impact of pandemic A(H1N1)pdm09 influenza and vaccine-associated adverse events on parental attitudes and influenza vaccine uptake in young childrenVaccine, 2014
- Effectiveness of Trivalent Flu Vaccine in Healthy Young ChildrenPediatrics, 2014
- Populations at risk for severe or complicated influenza illness: systematic review and meta-analysisBMJ, 2013
- Trivalent influenza vaccine and febrile adverse events in Australia, 2010: Clinical features and potential mechanismsVaccine, 2011
- Epidemiological study of severe febrile reactions in young children in Western Australia caused by a 2010 trivalent inactivated influenza vaccineBMJ Open, 2011
- Duplex Real-Time Reverse Transcriptase PCR Assays for Rapid Detection and Identification of Pandemic (H1N1) 2009 and Seasonal Influenza A/H1, A/H3, and B VirusesJournal of Clinical Microbiology, 2010
- An Economical Tandem Multiplex Real-Time PCR Technique for the Detection of a Comprehensive Range of Respiratory PathogensViruses, 2009
- Influenza-Associated Hospitalizations in the United StatesJAMA, 2004
- Influenza and the Rates of Hospitalization for Respiratory Disease among Infants and Young ChildrenNew England Journal of Medicine, 2000